
- English
- ePUB (mobile friendly)
- Available on iOS & Android
Oral Hypoglycemic Agents - ECAB
About this book
Even though we have many advances in the development of oral hypoglycemic agents, an ideal drug for treating type 2 diabetes is still a distant reality. Today, physicians can choose from a variety of medications targeting numerous facets of disease, but each drug class poses some limitations. The age-old molecules, such as sulfonylureas and biguanides, are still valued because of their well-studied mode of action, safety, tolerability, and predictable pharmacodynamic effects. This book attempts to describe the historical aspects and advances in the arena of oral hypoglycemic agents, extended- and sustained-release formulations of glipizide and metformin (both of which have great promise in the treatment of type 2 diabetes mellitus) as well as evaluates the role of the group in diabetic foot infections.
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- Cover image
- Title page
- Table of Contents
- Copyright
- ECAB Clinical Update: Diabetology
- Oral Hypoglycemic Agents
- About the Authors
- ECAB Clinical Update Information: Oral Hypoglycemic Agents
- Introduction
- Oral Hypoglycemic Agents: Historical Perspectives and Current Trends
- Emerging and Future Concepts of Oral Hypoglycemic Agents
- Metformin: An Old Drug Rediscovered
- Oral Hypoglycemic Agents and Diabetic Foot
- ECAB Clinical Update: Diabetology—Other Books in This Series